$17.76
-0.78-4.21%
Last update: Oct 27, 7:15 AM
Arcus Biosciences Inc (RCUS) Stock Price, Quote, News & History
RCUSNYSE
HC Wainwright lifted Arcus Biosciences' price target, citing broader revenue potential for casdatifan in first-line ccRCC.
You can purchase shares of Arcus Biosciences (NYSE:RCUS) through any online brokerage.
Other companies in Arcus Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Arcus Biosciences has a consensus price target of $36.88.
The stock price for Arcus Biosciences (NYSE: RCUS) is $17.76 last updated October 27, 2026 at 7:15 AM EDT.
There are no upcoming dividends for Arcus Biosciences.
Arcus Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Arcus Biosciences.
Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat,...
